Let’s Talk About It

Let’s Talk About It

As part of the CDC’s “End the HIV Epidemic” we have been working to reach populations who have been disproportionately impacted by HIV. Black/African American people account for a higher proportion of new HIV diagnoses and people with HIV, compared to other races and...
Injectable PrEP: A New Option for HIV Prevention

Injectable PrEP: A New Option for HIV Prevention

In 2022, the FDA approved a new form of PrEP, called injectable cabotegravir (brand name Apretude). Apretude is a single, long-acting injection that is given every two months. It is highly effective at preventing HIV infection, just like oral PrEP. Apretude may be a...
Translate »